Apogee Therapeutics, Inc. (APGE)

CIK 1974640 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Apogee Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 2026SCHEDULE 13D/A0001231919-26-001150
Sep 3, 202640001140361-26-035613
Sep 3, 2026S-8 POS0001140361-26-035587
Sep 3, 2026S-8 POS0001140361-26-035588
Sep 3, 202640001140361-26-035615
Sep 3, 202640001140361-26-035611
Sep 3, 202640001140361-26-035610
Sep 3, 2026POSASR0001140361-26-035593
Sep 3, 202640001140361-26-035612
Sep 3, 202640001104659-26-105119
Sep 3, 2026SCHEDULE 13D/A0001104659-26-105122
Sep 3, 2026S-8 POS0001140361-26-035589
Sep 3, 202625-NSE0001354457-26-000853
Sep 3, 202640001140361-26-035609
Sep 3, 202640001140361-26-035608
Sep 3, 2026S-8 POS0001140361-26-035586
Sep 3, 202640001140361-26-035614
Sep 3, 2026S-8 POS0001140361-26-035590
Sep 3, 20268-K0001140361-26-035537
Aug 11, 20268-K0001140361-26-032231
Aug 11, 202640001104659-26-094087
Aug 10, 202610-Q0001193125-26-341289
Aug 10, 20268-K0001193125-26-341239
Aug 7, 202640001104659-26-092838
Aug 6, 2026DEFA14A0001140361-26-031499